In this issue:
Standardised definitions for evaluating ADHF therapies
Optimising evidence-based HF medications after an acute HF admission
Clinical features of HFnEF
Aspirin and hemocompatibility events with an LVAD in advanced HF
Maternal and pregnancy outcomes following HT
A novel diagnostic HFRS using a minimally invasive sc ICM
Dapagliflozin (Forxiga) listed on PBS for chronic heart failure
Expanded access to empagliflozin (Jardiance)
Correction to focused update of ESC HF guidelines
Updated guidelines for diagnosing and managing AF
Recognising clinical trajectories using machine learning in hospitalised patients with HF
COVID-19 resources
Conferences, workshops and CPD
Please login below to download this issue (PDF)